Blons H - Search Results

1

Development and validation of a RNAseq signature for prognostic stratification in endometrial cancer.

Beinse G, Le Frere Belda MA, Just PA, Bekmezian N, Koual M, Garinet S, Leroy K, Letourneur F, Lusson A, Mulot C, Le Corre D, Metairie M, Delanoy N, Blons H, Gervais C, Durdux C, Chapron C, Goldwasser F, Terris B, Badoual C, Taly V, Laurent-Puig P, Borghese B, Bats AS, Alexandre J. Beinse G, et al. Among authors: blons h. Gynecol Oncol. 2022 Mar;164(3):596-606. doi: 10.1016/j.ygyno.2022.01.005. Epub 2022 Jan 13. Gynecol Oncol. 2022. PMID: 35033379

2

Sequence of molecular genetic events in colorectal tumorigenesis.

Laurent-Puig P, Blons H, Cugnenc PH. Laurent-Puig P, et al. Among authors: blons h. Eur J Cancer Prev. 1999 Dec;8 Suppl 1:S39-47. Eur J Cancer Prev. 1999. PMID: 10772417 Review.

3

Detection of free-circulating tumor-associated DNA in plasma of colorectal cancer patients and its association with prognosis.

Lecomte T, Berger A, Zinzindohoué F, Micard S, Landi B, Blons H, Beaune P, Cugnenc PH, Laurent-Puig P. Lecomte T, et al. Among authors: blons h. Int J Cancer. 2002 Aug 10;100(5):542-8. doi: 10.1002/ijc.10526. Int J Cancer. 2002. PMID: 12124803 Free article.

4

TP53 and head and neck neoplasms.

Blons H, Laurent-Puig P. Blons H, et al. Hum Mutat. 2003 Mar;21(3):252-7. doi: 10.1002/humu.10171. Hum Mutat. 2003. PMID: 12619110 Review.

5

[Cellular and neoplastic otorhinolaryngologic changes, molecular markers and therapeutic potential].

Blons H, Laccourreye O, Laurent-Puig P. Blons H, et al. Ann Otolaryngol Chir Cervicofac. 2003 Jun;120(3):152-60. Ann Otolaryngol Chir Cervicofac. 2003. PMID: 12843984 Review. French.

6

Prognostic significance of MMP-1 and MMP-3 functional promoter polymorphisms in colorectal cancer.

Zinzindohoué F, Lecomte T, Ferraz JM, Houllier AM, Cugnenc PH, Berger A, Blons H, Laurent-Puig P. Zinzindohoué F, et al. Among authors: blons h. Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):594-9. Clin Cancer Res. 2005. PMID: 15701845

7

Epidermal growth factor receptor mutation in lung cancer are linked to bronchioloalveolar differentiation.

Blons H, Côté JF, Le Corre D, Riquet M, Fabre-Guilevin E, Laurent-Puig P, Danel C. Blons H, et al. Am J Surg Pathol. 2006 Oct;30(10):1309-15. doi: 10.1097/01.pas.0000213285.65907.31. Am J Surg Pathol. 2006. PMID: 17001163

8

Genome wide SNP comparative analysis between EGFR and KRAS mutated NSCLC and characterization of two models of oncogenic cooperation in non-small cell lung carcinoma.

Blons H, Pallier K, Le Corre D, Danel C, Tremblay-Gravel M, Houdayer C, Fabre-Guillevin E, Riquet M, Dessen P, Laurent-Puig P. Blons H, et al. BMC Med Genomics. 2008 Jun 12;1:25. doi: 10.1186/1755-8794-1-25. BMC Med Genomics. 2008. PMID: 18549475 Free PMC article.

9

Mutations and response to epidermal growth factor receptor inhibitors.

Laurent-Puig P, Lievre A, Blons H. Laurent-Puig P, et al. Among authors: blons h. Clin Cancer Res. 2009 Feb 15;15(4):1133-9. doi: 10.1158/1078-0432.CCR-08-0905. Clin Cancer Res. 2009. PMID: 19228718 Review.

10

No somatic genetic change in the paxillin gene in nonsmall-cell lung cancer.

Pallier K, Houllier AM, Le Corre D, Cazes A, Laurent-Puig P, Blons H. Pallier K, et al. Among authors: blons h. Mol Carcinog. 2009 Jul;48(7):581-5. doi: 10.1002/mc.20538. Mol Carcinog. 2009. PMID: 19353596

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

156 results

Search Page